Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Targeting IL-17 and TH17 cells in chronic inflammation.

Miossec P, Kolls JK.

Nat Rev Drug Discov. 2012 Oct;11(10):763-76. doi: 10.1038/nrd3794. Review.

PMID:
23023676
2.

Interluekin-17A (IL17A).

Chen K, Kolls JK.

Gene. 2017 May 30;614:8-14. doi: 10.1016/j.gene.2017.01.016. Epub 2017 Jan 22. Review.

PMID:
28122268
3.

Targeting IL-17 in autoimmunity and inflammation.

Kim BS, Park YJ, Chung Y.

Arch Pharm Res. 2016 Nov;39(11):1537-1547. Epub 2016 Aug 30. Review.

PMID:
27576555
4.

The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.

Toussirot E.

Inflamm Allergy Drug Targets. 2012 Apr;11(2):159-68. Review.

PMID:
22280236
5.

IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.

Mitra A, Raychaudhuri SK, Raychaudhuri SP.

Actas Dermosifiliogr. 2014 Oct;105 Suppl 1:21-33. doi: 10.1016/S0001-7310(14)70015-8. Review.

PMID:
25398489
6.

Role of IL-17 and IL-22 in autoimmunity and cancer.

Blake SJ, Teng MW.

Actas Dermosifiliogr. 2014 Oct;105 Suppl 1:41-50. doi: 10.1016/S0001-7310(14)70017-1. Review.

PMID:
25398491
7.

IL-17 in the rheumatologist's line of sight.

Truchetet ME, Mossalayi MD, Boniface K.

Biomed Res Int. 2013;2013:295132. doi: 10.1155/2013/295132. Epub 2013 Jul 25. Review.

8.

The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo.

Liu C, Zhu L, Fukuda K, Ouyang S, Chen X, Wang C, Zhang CJ, Martin B, Gu C, Qin L, Rachakonda S, Aronica M, Qin J, Li X.

Sci Signal. 2017 Feb 21;10(467). pii: eaaf8823. doi: 10.1126/scisignal.aaf8823.

9.

IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.

Zhu S, Qian Y.

Clin Sci (Lond). 2012 Jun;122(11):487-511. doi: 10.1042/CS20110496. Review.

PMID:
22324470
10.

Interleukin 17A: toward a new understanding of psoriasis pathogenesis.

Lynde CW, Poulin Y, Vender R, Bourcier M, Khalil S.

J Am Acad Dermatol. 2014 Jul;71(1):141-50. doi: 10.1016/j.jaad.2013.12.036. Epub 2014 Mar 18. Review.

PMID:
24655820
11.

Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis.

Kirkham BW, Kavanaugh A, Reich K.

Immunology. 2014 Feb;141(2):133-42. doi: 10.1111/imm.12142. Review.

12.

Targeting the IL-17-T(H)17 pathway.

Bartlett HS, Million RP.

Nat Rev Drug Discov. 2015 Jan;14(1):11-2. doi: 10.1038/nrd4518. No abstract available.

PMID:
25549584
13.

The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.

Roeleveld DM, van Nieuwenhuijze AE, van den Berg WB, Koenders MI.

BioDrugs. 2013 Oct;27(5):439-52. doi: 10.1007/s40259-013-0035-4. Review.

PMID:
23620106
14.

IL-17RA in intestinal inflammation: structure, signaling, function, and clinical application.

Liu S, Ren J, Li J.

Inflamm Bowel Dis. 2015 Jan;21(1):154-66. doi: 10.1097/MIB.0000000000000217. Review.

PMID:
25272188
15.

The IL-17 pathway as a major therapeutic target in autoimmune diseases.

Hu Y, Shen F, Crellin NK, Ouyang W.

Ann N Y Acad Sci. 2011 Jan;1217:60-76. doi: 10.1111/j.1749-6632.2010.05825.x. Epub 2010 Dec 13. Review.

PMID:
21155836
16.

Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases.

Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K, Mizuguchi J, Itoh M, Kawakami Y, Yoshimoto T.

Clin Dev Immunol. 2013;2013:968549. doi: 10.1155/2013/968549. Epub 2013 Jul 14. Review.

17.

Pharmacologic inhibition of RORĪ³t regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.

Skepner J, Ramesh R, Trocha M, Schmidt D, Baloglu E, Lobera M, Carlson T, Hill J, Orband-Miller LA, Barnes A, Boudjelal M, Sundrud M, Ghosh S, Yang J.

J Immunol. 2014 Mar 15;192(6):2564-75. doi: 10.4049/jimmunol.1302190. Epub 2014 Feb 10.

18.

Interleukin-6-signal transducer and activator of transcription-3 signaling mediates aortic dissections induced by angiotensin II via the T-helper lymphocyte 17-interleukin 17 axis in C57BL/6 mice.

Ju X, Ijaz T, Sun H, Ray S, Lejeune W, Lee C, Recinos A 3rd, Guo DC, Milewicz DM, Tilton RG, Brasier AR.

Arterioscler Thromb Vasc Biol. 2013 Jul;33(7):1612-21. doi: 10.1161/ATVBAHA.112.301049. Epub 2013 May 16.

19.

Interleukin-17 signalling in a murine model of mild chronic asthma.

Herbert C, Shadie AM, Kumar RK.

Int Arch Allergy Immunol. 2013;162(3):253-62. doi: 10.1159/000353247. Epub 2013 Sep 6.

PMID:
24022125
20.

Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes.

Hot A, Miossec P.

Ann Rheum Dis. 2011 May;70(5):727-32. doi: 10.1136/ard.2010.143768. Epub 2011 Feb 22. Review.

PMID:
21345813

Supplemental Content

Support Center